Yahoo
TSXV - Free Realtime Quote CAD

Hydreight Technologies Inc. (NURS.V)

3.5500 +0.1000 (+2.90%)
As of 12:07:47 PM EDT. Market Open.
NURS.V Q2 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for NURS.V
  • Previous Close 3.4500
  • Open 3.3900
  • Bid 3.5200 x --
  • Ask 3.5500 x --
  • Day's Range 3.3900 - 3.5500
  • 52 Week Range 2.3800 - 5.5900
  • Volume 76,881
  • Avg. Volume 104,987
  • Market Cap (intraday) 190.512M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 27.31
  • EPS (TTM) 0.1300
  • Earnings Date Nov 26, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.25

Hydreight Technologies Inc. operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as a range of IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allows its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

hydreight.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NURS.V
17.44%
S&P/TSX Composite index (^GSPTSE)
12.78%

1-Year Return

NURS.V
7.58%
S&P/TSX Composite index (^GSPTSE)
25.60%

3-Year Return

NURS.V
1,009.38%
S&P/TSX Composite index (^GSPTSE)
74.93%

5-Year Return

NURS.V
1,477.78%
S&P/TSX Composite index (^GSPTSE)
72.83%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 24.93M
Earnings 2.59M
Profit Margin 10.38%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
5M
10M
15M
20M
2.0%
4.0%
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

8.25
9.25 Average
3.5500 Current
10.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    185.15M

  • Enterprise Value

    173.97M

  • Trailing P/E

    26.54

  • Forward P/E

    6.90

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    4.69

  • Enterprise Value/Revenue

    2.22

  • Enterprise Value/EBITDA

    20.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.64%

  • Return on Assets (ttm)

    9.03%

  • Return on Equity (ttm)

    21.54%

  • Revenue (ttm)

    55.78M

  • Net Income Avi to Common (ttm)

    4.26M

  • Diluted EPS (ttm)

    0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.21M

  • Total Debt/Equity (mrq)

    24.61%

  • Levered Free Cash Flow (ttm)

    -10.58M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: